SYNH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SYNH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-05), Syneos Health's current share price is $42.98. Syneos Health's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was $2.95. Syneos Health's Cyclically Adjusted Price-to-FCF for today is 14.57.
The historical rank and industry rank for Syneos Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Syneos Health's highest Cyclically Adjusted Price-to-FCF was 18.83. The lowest was 11.24. And the median was 13.97.
SYNH's Cyclically Adjusted Price-to-FCF is not rankedThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Syneos Health's adjusted free cash flow per share data for the three months ended in Jun. 2023 was $-0.495. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.95 for the trailing ten years ended in Jun. 2023.
The historical data trend for Syneos Health's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syneos Health Quarterly Data | ||||||||||||||||||||
Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | - | 18.24 | 12.63 | 12.32 | 14.93 |
For the Diagnostics & Research subindustry, Syneos Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Syneos Health's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Syneos Health's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 42.98 | / | 2.95 | |
= | 14.57 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syneos Health's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 is calculated as:
For example, Syneos Health's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Jun. 2023 (Change) | * | Current CPI (Jun. 2023) |
= | -0.495 | / | 128.7287 | * | 128.7287 | |
= | -0.495 |
Current CPI (Jun. 2023) = 128.7287.
Syneos Health Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201309 | 0.000 | 98.790 | 0.000 |
201312 | 0.000 | 98.326 | 0.000 |
201403 | 0.512 | 99.695 | 0.661 |
201406 | 0.783 | 100.560 | 1.002 |
201409 | 0.612 | 100.428 | 0.784 |
201412 | 0.110 | 99.070 | 0.143 |
201503 | 0.614 | 99.621 | 0.793 |
201506 | 0.808 | 100.684 | 1.033 |
201509 | 0.714 | 100.392 | 0.916 |
201512 | 0.931 | 99.792 | 1.201 |
201603 | -0.097 | 100.470 | -0.124 |
201606 | 0.683 | 101.688 | 0.865 |
201609 | 0.817 | 101.861 | 1.032 |
201612 | -0.003 | 101.863 | -0.004 |
201703 | 1.182 | 102.862 | 1.479 |
201706 | 0.313 | 103.349 | 0.390 |
201709 | -0.010 | 104.136 | -0.012 |
201712 | 0.697 | 104.011 | 0.863 |
201803 | -0.654 | 105.290 | -0.800 |
201806 | 0.970 | 106.317 | 1.174 |
201809 | 1.121 | 106.507 | 1.355 |
201812 | 0.930 | 105.998 | 1.129 |
201903 | -0.239 | 107.251 | -0.287 |
201906 | 0.765 | 108.070 | 0.911 |
201909 | 0.494 | 108.329 | 0.587 |
201912 | 1.397 | 108.420 | 1.659 |
202003 | -0.478 | 108.902 | -0.565 |
202006 | 1.669 | 108.767 | 1.975 |
202009 | 1.398 | 109.815 | 1.639 |
202012 | 0.975 | 109.897 | 1.142 |
202103 | 1.099 | 111.754 | 1.266 |
202106 | 0.738 | 114.631 | 0.829 |
202109 | 0.391 | 115.734 | 0.435 |
202112 | 1.515 | 117.630 | 1.658 |
202203 | 0.454 | 121.301 | 0.482 |
202206 | 0.732 | 125.017 | 0.754 |
202209 | 1.070 | 125.227 | 1.100 |
202212 | 0.971 | 125.222 | 0.998 |
202303 | 0.028 | 127.348 | 0.028 |
202306 | -0.495 | 128.729 | -0.495 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Syneos Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael J. Bonello | officer: Chief Financial Officer | 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612 |
Stanford Rudnick | officer: See remarks | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468 |
Christian Tucat | officer: Chief Business Officer | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468 |
Michael Lee Brooks | officer: See remarks | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
Jonathan Olefson | officer: General Counsel & Corp Secty | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
Michelle Keefe | officer: Pres., Commercial Solutions | C/O SYNEOS HEALTH,INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
Jason M. Meggs | officer: Chief Financial Officer | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
Donna Hildebrand Kralowetz | officer: SVP, Chief Accounting Officer | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
Matthew E. Monaghan | director | ONE INVACARE WAY, ELYRIA OH 44035 |
Alfonso G Zulueta | director | 4925 INDIANA AVE, LISLE IL 60532 |
Barbara W. Bodem | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Linda S Harty | director | MEDTRONIC PLC, 710 MEDTRONIC PARKWAY NE, LC-150, MINNEAPOLIS MN 55432 |
Alistair Macdonald | officer: Chief Operating Officer | C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560 |
David S. Wilkes | director | ONE BAXTER PARKWAY, DEERFIELD IL 60015 |
Advent International Corp/ma | 10 percent owner | 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199 |
From GuruFocus
By Marketwired • 09-15-2023
By PRNewswire • 09-21-2023
By Marketwired • 09-19-2023
By Marketwired • 09-17-2023
By PRNewswire • 09-19-2023
By Marketwired • 09-22-2023
By Marketwired • 09-18-2023
By PRNewswire • 09-26-2023
By Marketwired • 09-20-2023
By Marketwired • 09-26-2023